





Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
Blood Borne Pathogens: Module 4 questions with solved solutions
Typology: Exams
1 / 9
This page cannot be seen from the preview
Don't miss anything!
Blood Borne Pathogens - ANSWER>>Infectious microorganisms found in human blood. Hepatitis B (HBV) - ANSWER>>Liver infection transmitted through blood and fluids. Hepatitis C (HCV) - ANSWER>>Chronic liver infection spread via blood contact. HIV - ANSWER>>Virus causing acquired immunodeficiency syndrome (AIDS). Needle Stick Risk - ANSWER>>Infection risk from contaminated needles. HIV Infection Risk - ANSWER>>0.3% risk without gloves after needle stick. HCV Infection Risk - ANSWER>>3% risk without gloves after needle stick. HBV Infection Risk - ANSWER>>Up to 30% risk for non-immune workers. Glove Use - ANSWER>>Reduces infection risk by 50%. Immunization Availability - ANSWER>>Vaccines available for Hep. A and B only. Antigen Presence - ANSWER>>Indicates actual virus in infectious state. Antibody Presence - ANSWER>>Indicates recovery and immunity from infection. Anti-HBs - ANSWER>>Antibody against Hepatitis B surface antigen. Hepatitis Definition - ANSWER>>Inflammation of the liver, often viral. Bilirubin Buildup - ANSWER>>Causes jaundice due to liver dysfunction. Jaundice Symptoms - ANSWER>>Yellow skin and sclera due to bilirubin.
Hepatitis Virus Strains - ANSWER>>Five main strains: A, B, C, D, E. HAV Transmission - ANSWER>>Spread via contaminated food and water. Hepatitis A (HAV) - ANSWER>>Virus transmitted through fecal contamination. HAV Incubation Period - ANSWER>>Ranges from 15 to 50 days. Anti-HAV IgM - ANSWER>>Indicates recent Hepatitis A infection. Anti-HAV IgG - ANSWER>>Indicates past infection of Hepatitis A. Hepatitis A Vaccine - ANSWER>>Recommended for travelers to poor sanitation. Hepatitis B Virus - ANSWER>>Stable virus resistant to heat and disinfectants. HBV Antigens - ANSWER>>HBSAg, HBcAg, and HBeAg present in HBV. HBV Transmission - ANSWER>>Direct entry into bloodstream is most efficient. Asymptomatic HBV Infections - ANSWER>>60-70% of infections show no symptoms. Chronic Carriers - ANSWER>>Individuals who remain infected without symptoms. Hepatitis Symptoms - ANSWER>>Include jaundice, dark urine, and pale stool. B antigens - ANSWER>>Substances on HBV that trigger immune response. Symptomatic Infections - ANSWER>>Symptoms appear 2 weeks to 6 months post- exposure. Incubation period - ANSWER>>Average duration is 3 months for HBV. Viral replication - ANSWER>>Causes liver inflammation and various symptoms.
Routine practices - ANSWER>>Universal precautions to prevent HBV transmission. Hepatitis C - ANSWER>>Accounts for ≈ 20% of acute hepatitis cases. Chronic carriers - ANSWER>>More than half of infected individuals remain carriers. Acute episode - ANSWER>>Patient does not become a carrier after infection. Viral reservoir - ANSWER>>Hiding place of virus within infected cells. Blood exposure activities - ANSWER>>Includes shared needles and sexual activities. Infectivity duration - ANSWER>>Body fluids infectious for 6-7 years in carriers. Preventative immunization - ANSWER>>Vaccine series of 3 shots for HBV. Cirrhosis - ANSWER>>Liver scarring often from chronic hepatitis. Antiviral Medication - ANSWER>>Daily pills to treat chronic viral infections. Ribavirin - ANSWER>>Old antiviral treatment, less commonly prescribed. Sexual Transmission - ANSWER>>Inefficient virus spread through sexual contact. Mother to Baby Transmission - ANSWER>>Rare transmission of virus during childbirth. Hepatitis D (HDV) - ANSWER>>Defective virus needing HBV for replication. Fulminant Hepatitis - ANSWER>>Severe liver inflammation, often life-threatening. Immunization against HBV - ANSWER>>Best protection against Hepatitis D infection. Hepatitis E - ANSWER>>Fecal-oral transmission, serious for pregnant women.
Mortality Rate in Hepatitis E - ANSWER>>20% in pregnant females, higher than HAV. HAV - ANSWER>>Naked virus causing liver inflammation. HBV - ANSWER>>Enveloped virus, can cause chronic liver damage. HCV - ANSWER>>Enveloped virus, often asymptomatic in carriers. Transmission Routes - ANSWER>>Different methods of virus spread between hepatitis types. Vaccine Availability - ANSWER>>HAV and HBV have effective vaccines; HCV does not. AIDS - ANSWER>>Stage of HIV with opportunistic infections present. Reverse Transcriptase - ANSWER>>Enzyme converting viral RNA to DNA. gp120 - ANSWER>>Glycoprotein binding HIV to host cells. T-helper Lymphocytes - ANSWER>>Main target cells for HIV infection. Viral Dormancy - ANSWER>>Period where HIV DNA remains inactive in host. Viral Replication - ANSWER>>Process of producing new virus particles in host. Disinfection for HIV - ANSWER>>Standard methods effective against HIV contamination. HIV Culture - ANSWER>>Difficult to perform, not routinely done. Infective Dose - ANSWER>>Amount of virus needed to cause infection. CD4 Cells - ANSWER>>Helper cells crucial for immune system function.
Candida Yeast Infection - ANSWER>>Fungal infection prevalent in immunocompromised individuals. Herpes Reactivation - ANSWER>>Reactivation of herpes virus in AIDS patients. False Positives - ANSWER>>Incorrect positive test results for HIV antibodies. Immune Dysfunction - ANSWER>>Imbalance of CD4 and CD8 cells leading to susceptibility. Clinical Symptoms of AIDS - ANSWER>>Manifestations due to loss of CD4 cells. Nevirapine - ANSWER>>An antiretroviral drug used in HIV treatment. Multi-drug regime - ANSWER>>Combination of 3 or 4 drugs to prevent resistance. Opportunistic infections - ANSWER>>Infections occurring due to weakened immune system. HIV transmission - ANSWER>>Spread of HIV through body fluids containing lymphocytes. Most infectious fluid - ANSWER>>Blood is the most infectious body fluid for HIV. Infective dose - ANSWER>>Larger amount of virus needed compared to HBV. Routes of infection - ANSWER>>Ways HIV can enter a new host's body. Needle sharing - ANSWER>>Common transmission method among intravenous drug users. Mother-to-child transmission - ANSWER>>HIV can be transmitted during birth or breastfeeding. Casual contact - ANSWER>>Touching or kissing does not transmit HIV.
Accidental needle stick - ANSWER>>Most common risk for healthcare workers to contract HIV. Significant exposure - ANSWER>>Contact with patient blood on broken skin or mucous membranes. First response protocol - ANSWER>>Remove infective material and wash exposed area immediately. Prophylactic therapy - ANSWER>>Preventive treatment started after potential HIV exposure. Emerging infections - ANSWER>>New infections that can spread rapidly due to mutations. SARS-CoV-2 - ANSWER>>Virus responsible for COVID-19, identified in 2003. Zika virus - ANSWER>>Emerging infection recognized in 2016. Personal protective equipment - ANSWER>>Essential gear for healthcare workers to prevent infection. N95 respirator - ANSWER>>Mask required for healthcare workers during patient care. Hand hygiene - ANSWER>>Critical practice to prevent infection spread. Blood testing protocol - ANSWER>>Testing healthcare worker for HBV, HCV, and HIV after exposure. HBIG administration - ANSWER>>Hepatitis B immune globulin given after HBV exposure. Patient transport guidelines - ANSWER>>Specific protocols for moving patients to minimize infection risk.